Prevalence of Cardiovascular Disorders in Patients Aged 40 and More With Schizophrenia

• Conditions: Schizophrenia
• Interventions: Other: Data collection

• Registration Number: NCT05174533
• Lead Sponsor: Université de Reims Champagne-Ardenne

Brief Summary

Schizophrenia is a psychiatric disorder, affecting 600,000 patients in France. Patients with schizophrenia have life expectancy decrease from 10 to 20 years because of cardiovascular death. Cardiovascular risk factors are numerous: inadequate diet, smoking, alcohol consumption, diabetes, obesity. Primary prevention of cardiovascular risk in patients suffering from schizophrenia is difficult because of understaff in general practitioners and psychiatrists.

Detailed Description

The aim of the study is to describe prevalence of cardiovascular disorders in patients aged 40 and more with schizophrenia.

Study Timeline

• Study First Submitted: 2021-12-13
• Study First Submitted QC: 2021-12-13
• Study First Posted: 2021-12-30
• Status Verified: 2022-01
• Study Start: 2022-01-12
• Last Update Submitted: 2022-01-17
• Last Update Posted: 2022-02-01
• Primary Completion: 2022-05-12
• Study Completion: 2022-07-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• male or female
• aged of 40 and more
• with schizophrenia
• agreeing to participate in the study

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
with schizophrenia	Data collection	"with schizophrenia" group : patients aged 40 and more with schizophrenia

Primary Outcome Measures

Name	Time	Method
QRS morphology	Day 0	variation of QRS waves according a standard 12-lead ECG

Secondary Outcome Measures

Name	Time	Method
cardiac rhythm	Day 0	cardiac rhythm disorder according a standard 12-lead ECG

Trial Locations

Locations (1)

Epsmd de l'Aisne; 🇫🇷 Prémontré, Grand-Est, France